文献速递产科母胎医学

子痫前期并发症妊娠后的心血管事件:早发型与晚发型比较的系统综述与荟萃分析

Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2021-01-01

该系统综述与荟萃分析纳入73项研究,评估子痫前期(PE)病史女性远期心血管事件风险。有PE史者较正常妊娠史者复合心血管不良结局风险升高(OR 2.05,95%CI 1.9-2.3)。早发型PE较晚发型PE的复合心血管不良结局风险更高(OR 1.75,95%CI 1.0-3.0)。

要点

  • 有PE史女性复合心血管不良结局风险为正常妊娠史者的2.05倍(OR 2.05,95%CI 1.9-2.3)。
  • 有PE史女性高血压风险为正常妊娠史者的3.93倍(OR 3.93,95%CI 3.1-5.0)。
  • 早发型PE较晚发型PE主要心血管事件风险更高(OR 5.63,95%CI 1.5-21.4)。

核心结论

  • 早发型和晚发型PE均为女性远期不良心血管事件的风险因素。
  • 早发型PE较晚发型PE与更高的心血管疾病发病和死亡负担相关。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、EMBASE和Scopus数据库至2020年4月15日。
  • 纳入队列或病例对照设计研究,纳入首次妊娠时诊断为PE的女性,共纳入73项研究。
  • 遵循MOOSE指南和PRISMA声明,采用随机效应通用逆方差法合并数据。

主要发现

  • 有PE史女性较既往血压正常妊娠女性复合心血管不良结局风险更高(OR 2.05,95%CI 1.9-2.3)。
  • 有PE史女性较既往血压正常妊娠女性心血管死亡风险更高(OR 2.18,95%CI 1.8-2.7)。
  • 有PE史女性较既往血压正常妊娠女性主要心血管事件风险更高(OR 1.80,95%CI 1.6-2.0)。
  • 有PE史女性较既往血压正常妊娠女性高血压风险更高(OR 3.93,95%CI 3.1-5.0)。
  • 有PE史女性较既往血压正常妊娠女性需降压药物治疗风险更高(OR 4.44,95%CI 2.4-8.2)。

关键数值与推荐

  • 有PE史女性较既往血压正常妊娠女性血脂异常风险更高(OR 1.32,95%CI 1.3-1.4)。
  • 有PE史女性较既往血压正常妊娠女性2型糖尿病风险更高(OR 2.14,95%CI 1.5-3.0)。
  • 有PE史女性较既往血压正常妊娠女性肾功能异常风险更高(OR 3.37,95%CI 2.3-5.0)。
  • 有PE史女性较既往血压正常妊娠女性代谢综合征风险更高(OR 4.30,95%CI 2.6-7.1)。
  • 早发型PE女性较晚发型PE女性复合心血管不良结局风险更高(OR 1.75,95%CI 1.0-3.0)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To elucidate whether pre-eclampsia (PE) and the gestational age at onset of the disease (early- vs late-onset PE) have an impact on the risk of long-term maternal cardiovascular complications. METHODS: MEDLINE, EMBASE and Scopus databases were searched until 15 April 2020 for studies evaluating the incidence of cardiovascular events in women with a history of PE, utilizing combinations of the relevant MeSH terms, keywords and word variants for 'pre-eclampsia', 'cardiovascular disease' and 'outcome'. Inclusion criteria were cohort or case-control design, inclusion of women with a diagnosis of PE at the time of the first pregnancy, and sufficient data to compare each outcome in women with a history of PE vs women with previous normal pregnancy and/or in women with a history of early- vs late-onset PE. The primary outcome was a composite score of maternal cardiovascular morbidity and mortality, including cardiovascular death, major cardiovascular and cerebrovascular events, hypertension, need for antihypertensive therapy, Type-2 diabetes mellitus, dyslipidemia and metabolic syndrome. Secondary outcomes were the individual components of the primary outcome analyzed separately. Data were combined using a random-effects generic inverse variance approach. MOOSE guidelines and the PRISMA statement were followed. RESULTS: Seventy-three studies were included. Women with a history of PE, compared to those with previous normotensive pregnancy, had a higher risk of composite adverse cardiovascular outcome (odds ratio (OR), 2.05 (95% CI, 1.9-2.3)), cardiovascular death (OR, 2.18 (95% CI, 1.8-2.7)), major cardiovascular events (OR, 1.80 (95% CI, 1.6-2.0)), hypertension (OR, 3.93 (95% CI, 3.1-5.0)), need for antihypertensive medication (OR, 4.44 (95% CI, 2.4-8.2)), dyslipidemia (OR, 1.32 (95% CI, 1.3-1.4)), Type-2 diabetes (OR, 2.14 (95% CI, 1.5-3.0)), abnormal renal function (OR, 3.37 (95% CI, 2.3-5.0)) and metabolic syndrome (OR, 4.30 (95% CI, 2.6-7.1)). Importantly, the strength of the associations persisted when considering the interval (< 1, 1-10 or > 10 years) from PE to the occurrence of these outcomes. When stratifying the analysis according to gestational age at onset of PE, women with previous early-onset PE, compared to those with previous late-onset PE, were at higher risk of composite adverse cardiovascular outcome (OR, 1.75 (95% CI, 1.0-3.0)), major cardiovascular events (OR, 5.63 (95% CI, 1.5-21.4)), hypertension (OR, 1.48 (95% CI, 1.3-1.7)), dyslipidemia (OR, 1.51 (95% CI, 1.3-1.8)), abnormal renal function (OR, 1.52 (95% CI, 1.1-2.2)) and metabolic syndrome (OR, 1.66 (95% CI, 1.1-2.5). CONCLUSIONS: Both early- and late-onset PE represent risk factors for maternal adverse cardiovascular events later in life. Early-onset PE is associated with a higher burden of cardiovascular morbidity and mortality compared to late-onset PE. © 2020 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Dall'Asta A, D'Antonio F, Saccone G, et al. Cardiovascular events following pregnancy complicated by pre-eclampsia with emphasis on comparison between early- and late-onset forms: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2021. PMID: 32484256. doi:10.1002/uog.22107

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。